13 July 2010
DSM sells stake in Terreco to management.
DSM Venturing, the venture capital group of DSM, has sold its stake in Terreco Holding B.V. to the management of the company. Terreco has its headquarters at the Chemelot Campus in Geleen. Its principal activity is soil remediation using special technology.
21 April 2010
DSM Venturing has sold a small part of its equity stake in Provexis plc.
DSM Venturing, the corporate venturing unit of Royal DSM N.V., announces that it has sold a small part of its equity stake in Provexis plc, an AIM listed company that develops and licenses ingredients for the functional food, medical food and dietary supplement market. As a result of a prudent financial approach towards its investment portfolio, DSM Venturing opts to capitalize on part of the value created as a result of Provexis' shareprice development since DSM acquired its stake in August 2008. DSM remains a strategic stakeholder of the company, as illustrated by the recent announcement regarding the Letter of Intent for Provexis' Fruitflow technology with DSM Nutritional Products. After the sale announced today, DSM Venturing owns 197,769,230 shares, representing approximately 17.8% of the outstanding capital.
21 January 2010
DSM and Novomer to develop first CO2-based resin for coatings
Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, and Novomer Inc., based in Waltham (Massachusetts, United States), today announce that they have signed an agreement to jointly develop a revolutionary coating resin using carbon dioxide (CO2) as a raw material.
This development agreement follows a cooperation agreement and an investment by DSM Venturing in Novomer in 2007. The joint development project will benefit from the broad variety of DSM’s technologies and market access, in combination with the unique, efficient CO2 polymerization technology of Novomer.
11 January 2010
DSM invests in Bioprocess Control AB to optimize biogas processes
DSM Venturing, the corporate venturing unit of Royal DSM N.V., today announces that it has made an equity investment in Bioprocess Control AB, a market leader in providing advanced control technologies and services that enable the efficient design and optimal operation of biogas processes. In addition to the investment, a strategic cooperation agreement has been signed which will enable DSM and Bioprocess Control AB to leverage their complementary activities in the area of biogas.
7 January 2010
DSM invests in green chemistry company Segetis, Inc.
DSM Venturing, the corporate venturing unit of Royal DSM N.V., today announces that it has made an equity investment in US-based green chemistry company Segetis, Inc. Financial details of the investment will not be disclosed.
Segetis, Inc., based in Golden Valley (Minnesota, United States), has developed renewable chemistry which enables the use of non-food agricultural and forestry feedstock for production of sustainable materials. The company produces versatile, cost-effective chemical building blocks (monomers) called levulinic ketals which can be used to make new classes of chemicals and plastics with improved health and environmental footprint as well as novel performance attributes.
